Evolution of multiple sclerosis prevalence and phenotype in Latin America.

Abstract:

BACKGROUND:Literature regarding MS epidemiology and phenotype is scarce but has increased markedly over the past years. The objective of the present work is to assess the evolution of the prevalence and phenotype of MS in Latin America during recent years. METHODS:Review of literature. RESULTS:MS prevalence levels are low to medium in Latin America, although these have increased in recent years. A small latitudinal gradient has also been observed, but exceptions to this rule exist, suggesting other genetic and environmental factors ultimately influence regional prevalence rates. One of the distinctive features of the region is the complex genetic admixture arising from multiple divergent population ancestries in different countries including: Native Americans, Caucasians and Africans. Another variable which would lower MS risk in the region could be a protective effect linked to exposure to certain infections, such as parasites. Despite differences in MS epidemiology, Latin American patients show an MS phenotype very similar to that of Caucasian patients, and a progressively increasing female gender ratio as has been described worldwide. CONCLUSION:MS epidemiology in Latin American patients has distinctive features. Both, prevalence and incidence, are increasing.

authors

Negrotto L,Correale J

doi

10.1016/j.msard.2018.03.014

subject

Has Abstract

pub_date

2018-05-01 00:00:00

pages

97-102

eissn

2211-0348

issn

2211-0356

pii

S2211-0348(18)30101-9

journal_volume

22

pub_type

杂志文章,评审
  • Management of infusion related reactions associated with alemtuzumab in patients with multiple sclerosis.

    abstract:OBJECTIVE:Infusion-associated reactions (IARs) occur in >90% patients with multiple sclerosis (MS) treated with alemtuzumab. We aimed to study the frequency of IARs at 2 sites using 5 days of steroids (1g/day of IV methylprednisolone), but otherwise distinct protocols. METHODS:This was retrospective chart review of 38...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.msard.2017.07.019

    authors: Šega-Jazbec S,Barun B,Horvat Ledinek A,Fabekovac V,Krbot Skorić M,Habek M

    更新日期:2017-10-01 00:00:00

  • Temporal evolution of acute multiple sclerosis lesions on serial sodium (23Na) MRI.

    abstract:BACKGROUND:Several studies have reported the characteristics of acute multiple sclerosis (MS) lesions on diffusion-weighted magnetic resonance imaging (DWI MRI). Current publications reported a transient reduction of the apparent diffusion coefficient (ADC) delineating an early phase of lesion evolution, before increas...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2019.01.027

    authors: Eisele P,Konstandin S,Szabo K,Ebert A,Roßmanith C,Paschke N,Kerschensteiner M,Platten M,Schoenberg SO,Schad LR,Gass A

    更新日期:2019-04-01 00:00:00

  • Secondary hypersomnia as an initial manifestation of neuromyelitis optica spectrum disorders.

    abstract::The identification of AQP4-IgG, a specific and pathogenic antibody of NMO/SD has led to a broadening of the clinical spectrum of manifestations of NMO/SD including the presence of encephalic symptoms. Lesions are often distributed on peri‑ependymal area and sometimes affected the diencephalon leading to sleep disorder...

    journal_title:Multiple sclerosis and related disorders

    pub_type:

    doi:10.1016/j.msard.2019.101869

    authors: Beigneux Y,Arnulf I,Guillaume-Jugnot P,Leu-Semenescu S,Maillart E,Lubetzki C,Benveniste O,Papeix C

    更新日期:2020-02-01 00:00:00

  • Under-treated depression negatively impacts lifestyle behaviors, participation and health-related quality of life among older people with multiple sclerosis.

    abstract:PURPOSE:To what extent depression may negatively impact successful aging with multiple sclerosis (MS) is not known. We examined the impact of depression/depressive symptoms on lifestyle choices (diet, exercise, smoking and alcohol), participation and health-related quality of life (HRQoL) among older people living with...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.msard.2019.101919

    authors: Ploughman M,Wallack EM,Chatterjee T,Kirkland MC,Curtis ME,Health Lifestyle and Aging with MS Consortium.

    更新日期:2020-05-01 00:00:00

  • Erythroblast appearance associated with natalizumab.

    abstract::Despite having a high rate of occurrence, erythroblast appearance in peripheral blood may not be a recognized adverse effect of natalizumab (NTZ) treatment. Additionally, the time course and cause of erythroblast appearance remain unclear. We report two cases of multiple sclerosis wherein NTZ treatment led to erythrob...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2019.01.041

    authors: Kobayashi Y,Takamatsu R,Sato S,Watanabe R,Hoshi K,Ishii W,Yahikozawa H

    更新日期:2019-04-01 00:00:00

  • Longitudinal associations between brain structural changes and fatigue in early MS.

    abstract:BACKGROUND:Fatigue is a common and disabling symptom of multiple sclerosis (MS) patients. Structural changes in several brain areas have been reported to correlate with fatigue in MS patients but none consistently. OBJECTIVE:To study the association between global and regional measures of brain atrophy and fatigue in ...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2015.10.006

    authors: Nourbakhsh B,Azevedo C,Nunan-Saah J,Maghzi AH,Spain R,Pelletier D,Waubant E

    更新日期:2016-01-01 00:00:00

  • Forkhead box C1 gene variant causing glaucoma and small vessel angiopathy can mimic multiple sclerosis.

    abstract::A 34-year old Caucasian female was initially diagnosed with multiple small-vessel strokes at age 20 years which were etiologically classified as secondary to anti-phospholipid antibody syndrome (APS) although she had no history or laboratory data to suggest APS. Based on her MRI of brain findings, one of her neurologi...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2018.04.004

    authors: Avasarala JR,Jones JR,Rogers CR

    更新日期:2018-05-01 00:00:00

  • Neural cell adhesion molecules in brain plasticity and disease.

    abstract::Neural cell adhesion molecule (NCAM) has been studied extensively. But it is only in recent times that interest in this molecule has shifted to conditions such as Alzheimer's disease, Multiple Sclerosis and Schizophrenia, focusing on its role in neurodegeneration and abnormal neurodevelopment. NCAM is important in neu...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/j.msard.2012.08.002

    authors: Gnanapavan S,Giovannoni G

    更新日期:2013-01-01 00:00:00

  • Robot-guided ankle sensorimotor rehabilitation of patients with multiple sclerosis.

    abstract:BACKGROUND:People with multiple sclerosis (MS) often develop symptoms including muscle weakness, spasticity, imbalance, and sensory loss in the lower limbs, especially at the ankle, which result in impaired balance and locomotion and increased risk of falls. Rehabilitation strategies that improve ankle function may imp...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2016.12.006

    authors: Lee Y,Chen K,Ren Y,Son J,Cohen BA,Sliwa JA,Zhang LQ

    更新日期:2017-01-01 00:00:00

  • Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement.

    abstract:BACKGROUND:Leptomeningeal inflammation is associated with increased cortical damage and worse clinical outcomes in MS. It may be detected on contrast-enhanced T2-FLAIR imaging as focal leptomeningeal contrast-enhancement (LME). OBJECTIVE:To assess the safety of intrathecal (IT) rituximab in progressive MS (PMS) and to...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2019.02.013

    authors: Bhargava P,Wicken C,Smith MD,Strowd RE,Cortese I,Reich DS,Calabresi PA,Mowry EM

    更新日期:2019-05-01 00:00:00

  • Visual pathway involvement in multiple sclerosis: Look straight in the eyes.

    abstract::Visual symptoms are a common clinical manifestation of multiple sclerosis (MS) and are frequently due to acute optic neuritis (ON). However, the entire visual pathway can be involved throughout the disease course. We describe the case of a young MS patient who experienced visual symptoms that were eventually found to ...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2017.08.008

    authors: Gaetani L,Iaccheri B,Cerquaglia A,Gentili L,Fiore T,Di Gregorio M,Mancini A,Calabresi P,Cagini C,Sarchielli P,Di Filippo M

    更新日期:2017-10-01 00:00:00

  • Could Sars-Cov2 affect MS progression?

    abstract::A long-term neurologic sequela arising from COVID-19 infection in multiple sclerosis (MS) patients could be related both to the increase of cytokines and the activation of NLRP3 inflammasome by the Sars-CoV2. These two mechanisms may cause a worsening of MS several months after the resolution of the infection. ...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/j.msard.2020.102540

    authors: Di Stadio A,Romani L,Bernitsas E

    更新日期:2020-11-01 00:00:00

  • Targeting macrophages by an aza-anthrapyrazole to ameliorate experimental autoimmune encephalomyelitis.

    abstract:BACKGROUND:Multiple sclerosis (MS) is an immune-mediated neurodegenerative disease in the central nerve system, in which both innate and adaptive immune cells are involved. BBR3378, an aza-anthrapyrazole prevents experimental autoimmune encephalomyelitis (EAE), an inflammatory condition similar to MS, by antagonizing T...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2020.102190

    authors: Lin B,Launder D,Bailey DY,Assifuah FK,Miller OA,Conti HR,Du J,Koffman BM

    更新日期:2020-08-01 00:00:00

  • Clinical characteristics of 153 Brazilian patients with neuromyelitis optica spectrum disorder (NMOSD).

    abstract:BACKGROUND:The 2015 criteria for diagnosing neuromyelitis optica spectrum disorder (NMOSD) have encouraged several groups across the world to report on their patients using these criteria. The disease typically manifests with severe relapses of optic neuritis, longitudinally extensive myelitis and/or brainstem syndrome...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2018.11.031

    authors: Fragoso YD,Sousa NAC,Alves-Leon SV,Dias RM,Pimentel MLV,Gomes S,Goncalves MVM,Stella CV,Tauil CB,Anacleto A,Spessotto CV,Correa EC,Eboni ACB,Damasceno A,Damasceno B,Farinhas JGD,Mota RSS,Nogueira EGA,Pereira VCSR,Sc

    更新日期:2019-01-01 00:00:00

  • Multimodal neurophysiological evaluation of primary progressive multiple sclerosis - An increasingly valid biomarker, with limits.

    abstract:BACKGROUND:The promising utility of multi-modality evoked potential batteries to objectively measure multi-tract dysfunction has been evaluated by several groups using different methods. OBJECTIVE:To independently evaluate the use of multi-modality evoked potential batteries as surrogate biomarkers for both physical a...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2015.07.009

    authors: Canham LJ,Kane N,Oware A,Walsh P,Blake K,Inglis K,Homewood J,Witherick J,Faulkner H,White P,Lewis A,Furse-Roberts C,Cottrell DA

    更新日期:2015-11-01 00:00:00

  • Alemtuzumab as rescue therapy in case of multiple sclerosis rebound following Natalizumab break: Clinical case and literature review.

    abstract:INTRODUCTION:Natalizumab break exposes multiple sclerosis (MS) patients to a high risk of disease reactivation or rebound, whose prevention and treatment constitute a clinical challenge. CASE PRESENTATION:We describe a dramatic case of MS rebound, characterized by the development of severe neurological and psychiatric...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/j.msard.2019.03.002

    authors: Federle L,Puthenparampil M,Stenta G,Paolo G,Francesco P

    更新日期:2019-05-01 00:00:00

  • Application of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of Latin American patients.

    abstract:BACKGROUND:The 2015 International Panel for neuromyelitis optica (NMO) spectrum disorders (NMOSD) diagnosis (IPND) criteria was recently proposed. However, because there are no studies evaluating application of the IPND criteria in Latin American populations, we aimed to assess whether these new criteria improve the di...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2018.01.001

    authors: Carnero Contentti E,Soto de Castillo I,Daccach Marques V,López PA,Antunes Barreira A,Armas E,de Aquino Cruz C,Rubstein A,Lavigne Moreira C,Molina OM,Soto A,Tkachuk V

    更新日期:2018-02-01 00:00:00

  • The 20-year history: Change of multiple sclerosis patient profile over 20 years.

    abstract:BACKGROUND:Patients attending multiple sclerosis (MS) clinics experience less disability compared to previous years. OBJECTIVE:This study was conducted retrospectively examining the patient records of our MS Clinic. The patient records in 1996 were compared to those in 2016. METHODS:Demographic data, duration of dise...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2019.05.002

    authors: Ozakbas S,Cinar BP,Kahraman T,Multiple Sclerosis Research Group.

    更新日期:2019-08-01 00:00:00

  • A case of Takotsubo syndrome during a multiple sclerosis brainstem relapse.

    abstract:BACKGROUND:We report a case of a woman affected by relapsing remitting Multiple Sclerosis who developed acute left ventricular dysfunction in the context of a severe brainstem relapse, one month after an attempt of in-vitro fertilization. DISCUSSION:The characteristics of our case are consistent with the hypothesis of...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2018.05.005

    authors: Prestipino E,Squitieri M,Razzolini L,Pastò L,Forleo P,Amato MP

    更新日期:2018-08-01 00:00:00

  • Weight status and disability in multiple sclerosis: An examination of bi-directional associations over a 24-month period.

    abstract:BACKGROUND:Natural history studies have typically focused on non-modifiable factors as predictors of disability progression in multiple sclerosis (MS). Weight status has emerged as a correlate of disability status in cross-sectional studies of persons with MS and represents a possible modifiable predictor of disability...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2012.02.004

    authors: Pilutti LA,McAuley E,Motl RW

    更新日期:2012-07-01 00:00:00

  • Efficacy and safety of monoclonal antibody therapies for relapsing remitting multiple sclerosis: A network meta-analysis.

    abstract:BACKGROUND:Several monoclonal antibodies have been licensed for relapsing remitting multiple sclerosis (RRMS). It is still unclear which treatment regimen should be recommended due to the lack of head-to-head randomized controlled trials (RCTs). This study aims to investigate the relative efficacy and safety of existin...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.msard.2018.08.026

    authors: Xu X,Chi S,Wang Q,Li C,Xu B,Zhang J,Chen X

    更新日期:2018-10-01 00:00:00

  • A case of dextrocardia following maternal exposure to generic Fingolimod during the first trimester of pregnancy.

    abstract::Fingolimod, taken orally once per day, is approved for the treatment of relapsing-remitting multiple sclerosis (MS). It should be stopped at least two months before conception as it is not considered safe during pregnancy or when breast feeding. In vitro and animal studies have found a possibly increased risk of conge...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2018.02.015

    authors: Navardi S,Sahraian MA

    更新日期:2018-04-01 00:00:00

  • Factors Associated with Prescribing Oral Disease Modifying Agents in Multiple Sclerosis: a Real-world Analysis of Electronic Medical Records.

    abstract:BACKGROUND:Little is known about the factors associated with the selection of Disease Modifying Agents (DMA) for the management of Multiple Sclerosis (MS) since the introduction of oral DMAs in 2010. OBJECTIVES:To examine the factors associated with initiation of oral DMAs in patients with MS using data from electroni...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2020.102334

    authors: Earla JR,Hutton GJ,Thornton JD,Aparasu RR

    更新日期:2020-10-01 00:00:00

  • Positive association of herpes simplex virus-IgG with multiple sclerosis: A systematic review and meta-analysis.

    abstract:BACKGROUND:Multiple sclerosis (MS) is the most common chronic inflammatory demyelinating disease of the central nervous system (CNS), and whether herpes simplex virus (HSV) infection is associated with the development of MS remains controversial. We aimed to investigate potential associations between MS or clinically i...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2020.102633

    authors: Xu L,Zhang LJ,Yang L,Yang CS,Yi M,Zhang SN,Wang N,Huang CN,Liu MQ

    更新日期:2020-11-19 00:00:00

  • Emotion dysregulation in multiple sclerosis: Impact on symptoms of depression and anxiety.

    abstract:BACKGROUND:There is consistent evidence for higher prevalence of affective disorders, specifically mood and anxiety disorders, in people with MS (PwMS). PURPOSE:The goal of this study was to examine the role of emotion dysregulation in explaining symptoms of depression and anxiety in PwMS. METHODS:Data from 100 PwMS ...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2019.101399

    authors: Prakash RS,Schirda B,Valentine TR,Crotty M,Nicholas JA

    更新日期:2019-11-01 00:00:00

  • Prognostic value of odor identification impairment in multiple sclerosis: 10-Years follow-up.

    abstract:BACKGROUND:Olfactory dysfunction has been linked to clinical severity variables in multiple MS populations. Though, its prognostic value is still unknown. OBJECTIVE:The aim of this study was to explore the long-term outcome associated with Brief-Smell Identification Test (B-SIT) performance in a cohort of MS patients....

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2020.102486

    authors: da Silva AM,Torres C,Ferreira I,Moreira I,Samões R,Sousa AP,Santos E,Teixeira-Pinto A,Cavaco S

    更新日期:2020-11-01 00:00:00

  • The epidemiology of multiple sclerosis in the Scottish Highlands: Prevalence, incidence and time to confirmed diagnosis and treatment initiation.

    abstract:INTRODUCTION:Although multiple sclerosis (MS) is frequent in the northern hemisphere, there have not been recent epidemiological studies in the Scottish Highlands about MS. OBJECTIVES:To get updated data regarding MS prevalence, incidence and mortality in the Highlands. Time between symptom onset and MS diagnosis was ...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2020.102657

    authors: Carod-Artal FJ

    更新日期:2020-11-28 00:00:00

  • Lack of magnetic resonance imaging lesion activity as a treatment target in multiple sclerosis: An evaluation using electronically collected outcomes.

    abstract:BACKGROUND:The appropriate treatment target in multiple sclerosis (MS) is unclear. Lack of magnetic resonance imaging (MRI) lesion activity, a component of the no evidence of disease activity concept, has been proposed as a treatment target in MS. We used our MS database to investigate whether aggressively pursuing MRI...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2016.07.017

    authors: Conway DS,Thompson NR,Cohen JA

    更新日期:2016-09-01 00:00:00

  • Relative importance of vision and proprioception in maintaining standing balance in people with multiple sclerosis.

    abstract:BACKGROUND:Balance impairment is common and a risk factor of falls in people with multiple sclerosis (MS). The purpose of this study was to evaluate the relative importance between vision and proprioception in maintaining standing body balance among individuals with MS compared with healthy individuals. METHODS:Thirty...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章

    doi:10.1016/j.msard.2019.101901

    authors: Yang F,Liu X

    更新日期:2019-12-20 00:00:00

  • Patient needs and preferences in relapsing-remitting multiple sclerosis: A systematic review.

    abstract:BACKGROUND:Considering the multiple treatments approved for multiple sclerosis (MS) by the Food and Drug Administration (FDA) and European Medicines Agency (EMA), determining a treatment strategy for patients with clinically isolated syndrome (CIS) and relapsing-remitting MS (RRMS) can be challenging. To date, an overv...

    journal_title:Multiple sclerosis and related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/j.msard.2020.101929

    authors: Visser LA,Louapre C,Uyl-de Groot CA,Redekop WK

    更新日期:2020-01-02 00:00:00